AGI and the future of aging
In a quiet corner of a Shenzhen nursing home, a 2.4-kilogram robot uses AI algorithms to adapt to an elderly resident's walking posture and speed, offering mobility assistance that was unimaginable a decade ago. In a San Francisco laboratory, OpenAI's GPT-4b micro model designs proteins that could extend human lifespan by ten years. And in a university research center, a large language model fine-tuned on biological data predicts cellular aging with unprecedented accuracy.
These are not disconnected experiments. They are the leading edges of a transformation that will redefine what it means to grow old in the age of Artificial General Intelligence.
The Scientific Frontier
The most dramatic advances are happening at the molecular level. In January 2025, OpenAI unveiled GPT-4b micro, its first model focused on biological data—a language model that dreams up proteins capable of turning regular cells into stem cells. The model's suggestions made two of the Yamanaka factors—proteins central to cellular reprogramming—more than fifty times as effective as what scientists could achieve alone. "Just across the board, the proteins seem better than what the scientists were able to produce by themselves," said OpenAI researcher John Hallman.
This is only the beginning. In March 2026, researchers reported Longevity-LLM, a foundation model fine-tuned on DNA methylation, proteomics, and clinical data. It achieved state-of-the-art accuracy in epigenetic age prediction, surpassing established multi-tissue clocks. Meanwhile, a generative AI framework called AURORA now uses routine health data or even a facial image to generate comprehensive molecular profiles, opening the door to personalized aging interventions.
Perhaps most significantly, a 2025 study demonstrated that AI can design drugs that target aging's full complexity—not single pathways but the systemic breakdown of multiple systems simultaneously. When tested, the compounds extended lifespan in over 75% of cases, with one increasing lifespan by 74%. "Aging doesn't work that way," said Dr. Peter Fedichev, CEO of Gero. "It's systemic, intertwined, and defies one-dimensional solutions. That's what our approach embraces".
The Care Revolution
While scientists pursue longevity at the molecular level, AGI is already transforming how we care for older adults today. By 2030, one in six people worldwide will be over 65, with this number expected to double by 2050. The global care workforce simply cannot keep pace.
Agentic AI—systems powered by large language models that can make proactive, autonomous decisions—offers a path forward. These systems can personalize health tracking, manage cognitive care, and coordinate environmental monitoring, all aimed at enhancing independence and quality of life for older adults. In China alone, the market for elderly care robots is expected to reach 159 billion yuan by 2029, growing at 15% annually.
The technology is already here. By 2025,养老 robots had achieved breakthroughs in rehabilitation, nursing, and companionship. Rehabilitation robots now integrate assessment, training, and feedback into seamless systems. Companion robots have made significant advances in emotional recognition and interactive social functions. At the 2025 World Robot Conference, humanoid robots demonstrated the ability to understand natural language, plan tasks, and execute them—capabilities that will only deepen as AGI matures.
The Challenge of Dignity and Equity
Yet these advances raise profound questions. Agentic AI in elderly care brings concerns about data privacy, decision independence, and equitable access. Who decides when an AI system makes a care decision? How do we ensure that the benefits of longevity science reach everyone, not just those who can afford them?
As上海市养老服务和老龄产业协会 president Li Yong observed, AI is pushing elderly care from "basic subsistence toward quality enhancement, emotional companionship, and dignified aging". That shift—from survival to dignity—is perhaps the most profound implication of all.
The European Union's AI Act and WHO guidance have identified the 2025–2027 period as a critical window for establishing norms that ensure generative AI supports healthy aging by prioritizing dignity and equity. These are not optional additions. They are essential to ensuring that the AGI revolution in aging serves human flourishing rather than merely technological capability.
A New Vision of Aging
What does it mean to grow old when AGI can extend healthy life, provide autonomous care, and perhaps one day reverse aging itself?
For Global Future Nexus, this means advancing frameworks that ensure these technologies serve borderless human potential. It means building governance structures that protect dignity and autonomy while enabling innovation. And it means recognizing that aging is not a problem to be solved but a phase of life to be enriched—and that AGI, properly stewarded, can help us do exactly that.
The vision is not one of immortal bodies but of healthier, more meaningful later years—years in which technology amplifies human connection rather than replacing it. As the researchers developing these tools remind us, the goal is not just longer life, but better life.
That future is arriving faster than we think. The question is whether we will shape it with wisdom, equity, and compassion—or simply let it happen to us.
